Ideal Cure for Hepatitis B Infection: The Target is in Sight

被引：3
|
作者：
Anikhindi, Shrihari A. [1 ,2 ]
Kumar, Ashish [1 ,2 ]
Sharma, Praveen [1 ,2 ]
Singla, Vikas [1 ,2 ]
Bansal, Naresh [1 ,2 ]
Arora, Anil [1 ,2 ]
机构：
[1] Sir Ganga Ram Hosp, Dept Gastroenterol, New Delhi, India
[2] Sir Ganga Ram Hosp, Dept Pathol, New Delhi, India
来源：
JOURNAL OF CLINICAL AND EXPERIMENTAL HEPATOLOGY | 2018年 / 8卷 / 02期
关键词：
cccDNA; HBV; antivirals;
D O I：
10.1016/j.jceh.2017.10.002
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis B virus (HBV) is one of the most common causes of liver cirrhosis and hepatocellular carcinoma. Despite recent strides in pharmacotherapy, complete cure of HBV infection still remains an enigma. The biggest obstacle in HBV therapy is clearance of covalently closed circular deoxyribonucleic acid (cccDNA). We discuss about the role of cccDNA in HBV life cycle, efficacy and shortcomings of currently available antivirals as well as promising novel targets to achieve ideal HBV cure.
引用
收藏
页码：188 / 194
页数：7
相关论文
共 50 条
  • [21] Herbs cure hepatitis B
    不详
    JOURNAL OF SCIENTIFIC & INDUSTRIAL RESEARCH, 2000, 59 (04): : 337 - 337
  • [22] Achieving a cure in hepatitis B
    Dusheiko, G.
    ANTIVIRAL THERAPY, 2014, 19 : A16 - A16
  • [23] Closing in on a cure for hepatitis B
    Elie Dolgin
    Nature, 2022, 603 : S46 - S48
  • [24] NO CURE IN SIGHT
    GOUGH, PB
    PHI DELTA KAPPAN, 1994, 75 (08) : 579 - 579
  • [25] A cure in sight
    Cohen, P
    NEW SCIENTIST, 1998, 157 (2117) : 15 - 15
  • [26] Can antiviral therapy cure residual hepatitis B virus (HBV) infection? Studies of Entecavir in residual duck hepatitis B virus infection
    Reaiche, G. Y.
    Le Mire, M.
    Mason, W. S.
    Colonno, R.
    Jilbert, A. R.
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2008, 23 : A351 - A351
  • [27] Discovery of Novel cccDNA Reducers toward the Cure of Hepatitis B Virus Infection
    Chen, Dongdong
    Tan, Xuefei
    Chen, Wenming
    Liu, Yongfu
    Li, Chao
    Wu, Jun
    Zheng, Jiamin
    Shen, Hong C.
    Zhang, Meifang
    Wu, Waikwong
    Wang, Lin
    Xiong, Jing
    Dai, Jieyu
    Sun, Kai
    Zhang, Jitao David
    Xiang, Kunlun
    Li, Baocun
    Ni, XiaoJu
    Zhu, Qihui
    Gao, Lu
    Wang, Li
    Feng, Song
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (16) : 10938 - 10955
  • [28] Immunological biomarker discovery in cure regimens for chronic hepatitis B virus infection
    Gehring, Adam J.
    Mendez, Patricia
    Richter, Kirsten
    Ertl, Hildegund
    Donaldson, Eric F.
    Mishra, Poonam
    Maini, Mala
    Boonstra, Andre
    Lauer, Georg
    de Creus, An
    Whitaker, Kathleen
    Martinez, Sara Ferrando
    Weber, Jessica
    Gainor, Emily
    Miller, Veronica
    JOURNAL OF HEPATOLOGY, 2022, 77 (02) : 525 - 538
  • [29] Author Correction: Therapeutic strategies for hepatitis B virus infection: towards a cure
    Gregory C. Fanning
    Fabien Zoulim
    Jinlin Hou
    Antonio Bertoletti
    Nature Reviews Drug Discovery, 2020, 19 : 291 - 291
  • [30] Targeting cIAPs,a New Option for Functional Cure of Chronic Hepatitis B Infection?
    Hongyan Liu
    Jinlin Hou
    Xiaoyong Zhang
    Virologica Sinica, 2018, (05) : 459 - 461
12345